LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

Search

Elanco Animal Health Inc

Închisă

SectorSănătate

12.93 0.15

Rezumat

Modificarea prețului

24h

Curent

Minim

12.78

Maxim

12.99

Indicatori cheie

By Trading Economics

Venit

75M

67M

Vânzări

173M

1.2B

P/E

Medie Sector

17.093

56.602

EPS

0.37

Marjă de profit

5.616

Angajați

9,000

EBITDA

86M

261M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+13.06% upside

Dividende

By Dow Jones

Următoarele câștiguri

7 aug. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

1.6B

6.4B

Deschiderea anterioară

12.78

Închiderea anterioară

12.93

Scor tehnic

By Trading Central

Încredere

Bullish Evidence

Elanco Animal Health Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

5 mai 2025, 11:29 UTC

Achiziții, Fuziuni, Preluări

Elanco Sells Non-Core Asset to Blackstone for $295 Million

27 iun. 2024, 14:34 UTC

Principalele dinamici ale pieței

Elanco Shares Retreat Over Zenrelia Warning Label Concerns

5 mai 2025, 11:14 UTC

Achiziții, Fuziuni, Preluări

Elanco Sells Non-Core Asset to Blackstone for $295 Mln

5 mai 2025, 10:50 UTC

Achiziții, Fuziuni, Preluări

Elanco Animal Health: Monetization of This Non-Core Asset Will Be Used to Accelerate Debt Reduction >ELAN

5 mai 2025, 10:49 UTC

Achiziții, Fuziuni, Preluări

Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone for $295M

9 iul. 2024, 12:30 UTC

Achiziții, Fuziuni, Preluări

Merck Animal Health Completes Acquisition Of Elanco's Aqua Business >MRK

9 iul. 2024, 12:29 UTC

Achiziții, Fuziuni, Preluări

Elanco Animal Health Sees Ending 2024 With Net Debt to Adjusted Ebitda in Mid-4x Range >ELAN

9 iul. 2024, 12:28 UTC

Achiziții, Fuziuni, Preluări

Elanco Animal Health: $1.05B-$1.1B Net Proceeds Available for Debt Paydown in 3Q >ELAN

9 iul. 2024, 12:28 UTC

Achiziții, Fuziuni, Preluări

Elanco Completes Sale of Aqua Business to Merck >ELAN MRK

Comparație

Modificare preț

Elanco Animal Health Inc Așteptări

Obiectiv de preț

By TipRanks

13.06% sus

Prognoză pe 12 luni

Medie 14.63 USD  13.06%

Maxim 20 USD

Minim 10 USD

În baza a 11 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruElanco Animal Health Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

11 ratings

7

Cumpărare

4

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

9.77 / N/ASuport & Rezistență

Termen scurt

Bullish Evidence

Termen mediu

Strong Bullish Evidence

Termen lung

Weak Bullish Evidence

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Elanco Animal Health Inc

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.